Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Keep informed on insider trading with our comprehensive news coverage. Explore the latest insider stock trades, follow insider trading activity, and dive into detailed reports on recent cases. Whether you’re monitoring the markets or interested in today’s top headlines, our insider trades tracker provides timely insights and updates.
Kevin J. O’Connor, a director at Procore Applied sciences , Inc. (NYSE:PCOR), a development administration software program firm with an $11.4 billion market cap and robust monetary well being based on InvestingPro, lately bought a good portion of his holdings…
In latest transactions reported to the Securities and Trade Fee, Topline Capital Administration, LLC, led by its managing member Collin McBirney, disclosed the sale of Paysign, Inc. (NASDAQ:PAYS) widespread inventory totaling $863,044. These gross sales occurred over two days, with…
Alejandra Carvajal, the Senior Vice President and Chief Authorized Officer of Mersana Therapeutics, Inc. (NASDAQ:MRSN), not too long ago performed a inventory transaction in keeping with a Type 4 submitting with the Securities and Alternate Fee. On January 14, Carvajal…
CAMBRIDGE, MA—Bala Mohan, the Senior Vice President and Chief Improvement Officer of Mersana Therapeutics, Inc. (NASDAQ:MRSN), just lately executed a sequence of inventory transactions, in keeping with a submitting with the Securities and Trade Fee. On January 14, Mohan offered…
Timothy B. Lowinger, the Senior Vice President and Chief Science & Expertise Officer at Mersana Therapeutics, Inc. (NASDAQ:MRSN), not too long ago reported a sale of firm inventory. In response to the SEC submitting, Lowinger offered 3,483 shares of frequent…
CAMBRIDGE, MA—Brian DeSchuytner, Senior Vice President, Chief Working Officer, and Chief Monetary Officer of Mersana Therapeutics, Inc. (NASDAQ:MRSN), just lately executed a sale of firm inventory, based on a current SEC submitting. The transaction comes as the corporate’s inventory trades…
On yesterday, January 13, 2025, Ashish acquired 2,646 shares of frequent inventory via the vesting of RSUs, with no money exchanged on this transaction. Following these transactions, Ashish holds a complete of 49,396 shares of Mersana Therapeutics (NASDAQ:MRSN) frequent inventory.…
The sale was performed to cowl tax withholding obligations associated to the vesting and settlement of restricted inventory models (RSUs). These RSUs had been initially awarded to Protopapas, who beforehand served as the corporate’s President and CEO. As a part…
Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a $454 million market cap biotech firm, not too long ago reported that its Chief Govt Officer, Jon Congleton, bought 18,333 shares of widespread inventory. The transactions occurred on January 13, 2025, at a weighted common…
Adam Scott Levy, the Chief Monetary Officer and Secretary of Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a clinical-stage biotech firm with a market capitalization of $454 million, lately executed a sequence of inventory gross sales in response to a submitting with the…
